Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 20185814)

1.

Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study.

Carstensen M, Herder C, Kivimäki M, Jokela M, Roden M, Shipley MJ, Witte DR, Brunner EJ, Tabák AG.

Diabetes. 2010 May;59(5):1222-7. doi: 10.2337/db09-1199. Epub 2010 Feb 25.

2.

Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study.

Herder C, Brunner EJ, Rathmann W, Strassburger K, Tabák AG, Schloot NC, Witte DR.

Diabetes Care. 2009 Mar;32(3):421-3. doi: 10.2337/dc08-1161. Epub 2008 Dec 10.

3.

Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study.

Tabák AG, Carstensen M, Witte DR, Brunner EJ, Shipley MJ, Jokela M, Roden M, Kivimäki M, Herder C.

Diabetes Care. 2012 Dec;35(12):2540-7. doi: 10.2337/dc11-2263. Epub 2012 Aug 28.

4.

Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus.

Ybarra J, Lehmann TN, Golay A, Juge-Aubry CE, Roux-Lombard P, Dayer JM, Meier CA.

Diabetes Metab. 2008 Feb;34(1):75-81. doi: 10.1016/j.diabet.2007.10.006. Epub 2008 Feb 1.

5.

The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder.

Lotrich FE, Butters MA, Aizenstein H, Marron MM, Reynolds CF 3rd, Gildengers AG.

Int J Geriatr Psychiatry. 2014 Jun;29(6):635-44. doi: 10.1002/gps.4048. Epub 2013 Nov 25.

PMID:
24273017
6.

Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis.

Comabella M, Julià E, Tintoré M, Brieva L, Téllez N, Río J, López C, Rovira A, Montalban X.

J Neurol. 2008 Aug;255(8):1136-41. doi: 10.1007/s00415-008-0855-1. Epub 2008 May 20.

PMID:
18484235
7.

Associations between interleukin-1 (IL-1) gene variations or IL-1 receptor antagonist levels and the development of type 2 diabetes.

Luotola K, Pietilä A, Zeller T, Moilanen L, Kähönen M, Nieminen MS, Kesäniemi YA, Blankenberg S, Jula A, Perola M, Salomaa V; Health 2000 and FINRISK97 Studies.

J Intern Med. 2011 Mar;269(3):322-32. doi: 10.1111/j.1365-2796.2010.02294.x.

PMID:
21205020
8.

Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes.

Larsen CM, Faulenbach M, Vaag A, Ehses JA, Donath MY, Mandrup-Poulsen T.

Diabetes Care. 2009 Sep;32(9):1663-8. doi: 10.2337/dc09-0533. Epub 2009 Jun 19.

9.

Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes.

Pfleger C, Mortensen HB, Hansen L, Herder C, Roep BO, Hoey H, Aanstoot HJ, Kocova M, Schloot NC; Hvidøre Study Group on Childhood Diabetes.

Diabetes. 2008 Apr;57(4):929-37. doi: 10.2337/db07-1697. Epub 2008 Feb 25.

10.

Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR.

Lancet. 2009 Jun 27;373(9682):2215-21. doi: 10.1016/S0140-6736(09)60619-X. Epub 2009 Jun 8.

11.

Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study.

Carstensen M, Herder C, Brunner EJ, Strassburger K, Tabak AG, Roden M, Witte DR.

Eur J Endocrinol. 2010 May;162(5):913-7. doi: 10.1530/EJE-09-1066. Epub 2010 Feb 18.

12.

Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.

Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ.

J Manag Care Pharm. 2010 May;16(4):264-75.

13.

Interleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgery.

Szczesny TJ, Slotwinski R, Stankiewicz A, Szczygiel B, Zaleska M, Kopacz M.

Eur J Cardiothorac Surg. 2007 Apr;31(4):719-24. Epub 2007 Feb 20.

PMID:
17317198
14.

Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4.

Pham MN, Hawa MI, Pfleger C, Roden M, Schernthaner G, Pozzilli P, Buzzetti R, Scherbaum WA, Seissler J, Kolb H, Hunter S, Leslie RD, Schloot NC; Action LADA Study Group.

Diabetologia. 2011 Jul;54(7):1630-8. doi: 10.1007/s00125-011-2088-6. Epub 2011 Feb 24. Erratum in: Diabetologia. 2012 Feb;55(2):534. Scherbaum, W [corrected to Scherbaum, W A].

PMID:
21347621
15.
16.

Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury.

Mandrup-Poulsen T, Wogensen LD, Jensen M, Svensson P, Nilsson P, Emdal T, Mølvig J, Dinarello CA, Nerup J.

Crit Care Med. 1995 Jan;23(1):26-33.

PMID:
8001382
17.

[Correlation between interleukin-1 and the obesity of polycystic ovary syndrome].

Yang Y, Qiao J, Li MZ.

Zhonghua Fu Chan Ke Za Zhi. 2012 Jan;47(1):9-13. Chinese.

PMID:
22455686
18.

Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans.

Pihlajamäki J, Kuulasmaa T, Kaminska D, Simonen M, Kärjä V, Grönlund S, Käkelä P, Pääkkönen M, Kainulainen S, Punnonen K, Kuusisto J, Gylling H, Laakso M.

J Hepatol. 2012 Mar;56(3):663-70. doi: 10.1016/j.jhep.2011.10.005. Epub 2011 Oct 23.

PMID:
22027586
20.

Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits.

Herder C, Nuotio ML, Shah S, Blankenberg S, Brunner EJ, Carstensen M, Gieger C, Grallert H, Jula A, Kähönen M, Kettunen J, Kivimäki M, Koenig W, Kristiansson K, Langenberg C, Lehtimäki T, Luotola K, Marzi C, Müller C, Peters A, Prokisch H, Raitakari O, Rathmann W, Roden M, Salmi M, Schramm K, Swerdlow D, Tabak AG, Thorand B, Wareham N, Wild PS, Zeller T, Hingorani AD, Witte DR, Kumari M, Perola M, Salomaa V.

Diabetes. 2014 Dec;63(12):4343-59. doi: 10.2337/db14-0731. Epub 2014 Jun 26.

PMID:
24969107
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk